Oncology Institute, Inc.TOIIWEarnings & Financial Report
TOIIW Q4 2025 Key Financial Metrics
营收
$142.0M
毛利润
N/A
营业利润
$-6.9M
净利润
$-7.5M
毛利率
N/A
营业利润率
-4.9%
净利率
-5.3%
同比增长
41.6%
EPS
$-0.04
资金流向
Oncology Institute, Inc. Q4 2025 Financial Summary
Oncology Institute, Inc. reported revenue of $142.0M (up 41.6% YoY) for Q4 2025, with a net profit of $-7.5M (up 43.0% YoY) (-5.3% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $142.0M |
|---|---|
| Net Profit | $-7.5M |
| Gross Margin | N/A |
| Operating Margin | -4.9% |
| Report Period | Q4 2025 |
Revenue Breakdown
Oncology Institute, Inc. Q4 2025 revenue of $142.0M breaks down across 3 segments, led by Other at $82.1M (57.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Other | $82.1M | 57.8% |
| Fee For Service | $36.3M | 25.5% |
| Capitated Revenue | $23.6M | 16.6% |
Oncology Institute, Inc. Revenue by Segment — Quarterly Trend
Oncology Institute, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Other and Fee For Service) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Other | $82.1M | — | — | — |
| Fee For Service | $36.3M | $39.6M | $37.0M | $35.6M |
| Capitated Revenue | $23.6M | $20.6M | $18.8M | $17.5M |
Oncology Institute, Inc. Annual Revenue by Year
Oncology Institute, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $502.7M). Click any linked year to see what changed vs the prior 10-K.
Oncology Institute, Inc. Quarterly Revenue & Net Profit History
Oncology Institute, Inc. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $142.0M | +41.6% | $-7.5M | -5.3% |
| Q3 2025 | $136.6M | +36.7% | $-16.5M | -12.1% |
| Q2 2025 | $119.8M | +21.5% | $-17.0M | -14.2% |
| Q1 2025 | $104.4M | +10.3% | $-19.6M | -18.8% |
| Q4 2024 | $100.3M | +16.9% | $-13.2M | -13.1% |
| Q3 2024 | $99.9M | +21.8% | $-16.1M | -16.1% |
| Q2 2024 | $98.6M | +22.9% | $-15.5M | -15.7% |
| Q1 2024 | $94.7M | +24.2% | $-19.9M | -21.0% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $94.7M | $98.6M | $99.9M | $100.3M | $104.4M | $119.8M | $136.6M | $142.0M |
| 同比增长 | 24.2% | 22.9% | 21.8% | 16.9% | 10.3% | 21.5% | 36.7% | 41.6% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $204.5M | $179.6M | $179.2M | $172.7M | $164.0M | $159.8M | $163.6M | $164.7M |
| 总负债 | $163.2M | $150.4M | $163.7M | $169.1M | $158.9M | $168.8M | $175.9M | $180.4M |
| 股东权益 | $41.3M | $29.2M | $15.5M | $3.6M | $5.1M | $-9.0M | $-12.3M | $-15.7M |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $-15.9M | $-15.7M | $819000 | $4.2M | $-5.0M | $-10.2M | $-12.6M | $3.2M |